Corixa Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 263

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $300M

Corixa General Information

Description

Developer of immunotherapeutics. The company develops immunotherapeutics to combat autoimmune diseases, infectious diseases and cancer.

Contact Information

Website
www.corixa.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1900 9Th Avenue
  • Suite 1100
  • Seattle, WA 98101
  • United States
+1 (206)
Primary Industry
Biotechnology
Acquirer
GSK
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1900 9Th Avenue
  • Suite 1100
  • Seattle, WA 98101
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Corixa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 29-Apr-2005 $300M Completed Generating Revenue
7. Grant 06-Jan-2004 Completed Generating Revenue
6. PIPE 24-Jun-2003 Completed Generating Revenue
5. PIPE 19-Aug-2002 Completed Generating Revenue
4. Grant 12-Aug-2002 Completed Generating Revenue
3. Grant 01-Nov-2000 Completed Generating Revenue
2. Early Stage VC (Series B) 10-May-1996 $5M $20.3M Completed Startup
1. Early Stage VC (Series A) 02-Dec-1994 $15.3M $15.3M Completed Startup
To view Corixa’s complete valuation and funding history, request access »

Corixa Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Corixa’s complete cap table history, request access »

Corixa Patents

  • 1,567

    Total Documents Applications and Grants

  • Total Patents Families

  • 315

    Granted

  • 31

    Pending

  • Expiring in next 12 mo

Corixa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240115688-A1 Novel antigens Pending 02-Dec-2020
US-20230234992-A1 Modified betacoronavirus spike proteins Pending 05-Jun-2020
US-11278613-B2 Lyssavirus antigen constructs Active 17-Jul-2017
US-20200222526-A1 Lyssavirus antigen constructs Active 17-Jul-2017
US-10967057-B2 Zika viral antigen constructs Active 02-Jun-2016 A61K39/12
To view Corixa’s complete patent history, request access »

Corixa Executive Team (4)

Name Title Board Seat
Mark Mcdade Founder
You’re viewing 1 of 4 executive team members. Get the full list »

Corixa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corixa Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axiom Venture Partners Venture Capital Minority
Costanoa Ventures Venture Capital Minority
Forward Ventures Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
InterWest Health Partners Corporate Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Corixa Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Coulter Pharmaceutical 16-Oct-2000 Biotechnology
ImmGenics Pharmaceuticals 01-Nov-1998 Biotechnology
GenQuest 16-Sep-1998 Merger/Acquisition Biotechnology
To view Corixa’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Corixa Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
ImmGenics Pharmaceuticals 01-Nov-1998 Completed
To view Corixa’s complete exits history, request access »

Corixa FAQs

  • When was Corixa founded?

    Corixa was founded in 1994.

  • Who is the founder of Corixa?

    Steven Gillis Ph.D and Mark Mcdade are the founders of Corixa.

  • Where is Corixa headquartered?

    Corixa is headquartered in Seattle, WA.

  • What is the size of Corixa?

    Corixa has 263 total employees.

  • What industry is Corixa in?

    Corixa’s primary industry is Biotechnology.

  • Is Corixa a private or public company?

    Corixa is a Private company.

  • What is the current valuation of Corixa?

    The current valuation of Corixa is .

  • What is Corixa’s current revenue?

    The current revenue for Corixa is .

  • How much funding has Corixa raised over time?

    Corixa has raised $195M.

  • Who are Corixa’s investors?

    Axiom Venture Partners, Costanoa Ventures, Forward Ventures, Frazier Healthcare Partners, and InterWest Health Partners are 5 of 18 investors who have invested in Corixa.

  • When was Corixa acquired?

    Corixa was acquired on 29-Apr-2005.

  • Who acquired Corixa?

    Corixa was acquired by GSK.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »